Filing Flows › Biolife Solutions (BLFS) › R&D spending
Biolife Solutions (BLFS) R&D spending by quarter
Biolife Solutions' R&D spending was $3.0M in Q2 2026 (second quarter 2026), +12% from Q1 2026. Over the last 4 quarters it ranged from $2.6M (Q1 2026) to $3.0M (Q2 2026).
| Quarter | R&D spending | Q/Q | Y/Y |
|---|---|---|---|
| Q2 2026 | $3.0M | +12% | +9% |
| Q1 2026 | $2.6M | -2% | — |
| Q3 2025 | $2.7M | -0.4% | — |
| Q2 2025 | $2.7M | — | — |
Q2 2026 at a glance
Biolife Solutions, Q2 2026: revenue $28.5M (+22% year over year), operating margin 6.0%, net earnings $45.1M, operating cash flow $6.3M. The chart follows the revenue to costs, profit and cash.
Questions
What is Biolife Solutions' R&D spending?
Biolife Solutions' R&D spending was $3.0M in Q2 2026 (second quarter 2026), +12% from Q1 2026.
How has Biolife Solutions' R&D spending changed?
Over the last 4 quarters it ranged from $2.6M (Q1 2026) to $3.0M (Q2 2026).